Related Experiment Video
Updated: Mar 22, 2026
09:20
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
7.2K
Pathophysiology and management of multivalvular disease
Philippe Unger1, Marie-Annick Clavel2, Brian R Lindman3
1Cardiology Department, CHU Saint-Pierre, Université Libre de Bruxelles, 322 rue Haute, B-1000, Brussels, Belgium.
Nature Reviews. Cardiology
|April 29, 2016
Summary
Multivalvular disease (MVD) diagnosis and treatment are complex due to multiple valve issues. A multidisciplinary team approach, considering patient factors and evolving therapies like transcatheter options, is crucial for optimal outcomes.
Area of Science:
- Cardiology
- Cardiac Surgery
- Medical Diagnostics
Background:
- Multivalvular disease (MVD) presents complex challenges in diagnosis and management.
- Existing diagnostic methods are often validated for single-valve disease, complicating MVD assessment.
- MVD pathophysiology varies significantly based on the specific combination of affected valves.
Purpose of the Study:
- To review the pathophysiology, diagnosis, and treatment of multivalvular disease.
- To focus on the most common combinations of valve pathologies encountered in clinical practice.
- To highlight evolving treatment strategies, including transcatheter valve therapies.
Main Methods:
- Review of current literature on multivalvular disease.
- Analysis of diagnostic challenges with echocardiography in MVD.
- Discussion of treatment decision-making factors for MVD patients.
- Exploration of combined surgical and transcatheter treatment approaches.
Main Results:
- Diagnosis of MVD is challenging due to limitations of current echocardiographic methods.
- Treatment decisions require careful consideration of disease severity, patient factors, surgical risk, and prosthesis longevity.
- Transcatheter valve therapies offer new options, necessitating evolving decision-making algorithms.
Conclusions:
- A multidisciplinary heart valve team approach is essential for individualized MVD management.
- Case-by-case evaluation considering multiple clinical factors is critical for treatment planning.
- The integration of transcatheter therapies is rapidly changing the landscape of MVD treatment.
More Related Videos
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
424
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
424
01:25Aortic Regurgitation III: Medical Management
544
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
544
01:25Mitral Regurgitation III: Medical Management
516
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
516
01:29Cardiomyopathy V: Interprofessional Care
605
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
605
01:22Mitral Valve Prolapse II: Assessment and Management
1.0K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.0K
01:27Mitral Stenosis IV: Nursing Management
359
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
359